Observational studyBMC surgery2025
Retrospective study comparing three approaches for keloids: surgery + radiotherapy, surgery + pharmacological injection, and surgery alone.
Observational study in BMC surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveTo investigate the differential efficacy of various treatment modalities adjunct to surgical excision of keloids and to analyze prognostic factors influencing outcomes. METHODOLOGY: A retrospective observational study approach was employed. Clinical data from 121 patients with keloids who met the inclusion criteria were collected for analysis of clinical characteristics and evaluation of treatment efficacy. The patients were categorized into three groups based on the adjuvant treatment modalities utilized post-surgical excision of keloids: surgical + radiotherapy group (group A), surgical + radiotherapy + pharmacological injection group (group B), and surgical group (group C). Factors potentially influencing treatment outcomes-such as treatment modality, gender, age, lesion distribution, lesion size, duration of the condition, and prior treatments-were subjected to a statistical analysis. Significant risk factors were identified through univariate analysis.
resultsThe efficacy rates for group A, group B, and group C were 93.88%, 87.04%, and 55.56%, respectively. Statistical analysis indicated that age and treatment modality were significant risk factors for recurrence.
conclusionThe application of radiotherapy post-surgery, or a combination of radiotherapy and pharmacological injections postoperatively, has been demonstrated to significantly reduce the recurrence rate of keloids. Conversely, the efficacy of treatments that solely rely on surgery is comparatively lower. For elderly patients, early intervention upon the manifestation of clinical symptoms is strongly advocated, with a preference for adjunctive postoperative radiotherapy to mitigate the risk of recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.